Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mangiferin is a naturally occurring C-glucosyl xanthone (xanthonoid) primarily found in the leaves and bark of Mangifera indica (mango tree), as well as other plant species. It is a bioactive polyphenol with a wide range of pharmacological activities demonstrated in vitro and in vivo studies. These include antioxidative, anti-inflammatory, antitumor (anticancer), antibacterial, antiviral, immunomodulatory, antidiabetic (glucose-lowering), hepatoprotective (liver-protecting), cardioprotective and neuroprotective effects[1][4][7]. Mechanistically it acts through multiple molecular pathways such as reducing oxidative stress and inflammation; modulating AMPK/TBK1 signaling; restoring PDE3B stability to regulate lipid metabolism; inhibiting noncanonical NF-κB activation; and affecting glucose/lipid homeostasis[4]. Despite its promising therapeutic potential for chronic diseases like diabetes mellitus type 2/NAFLD/obesity/cardiovascular disease/neurodegenerative disorders/cancer/liver disease/kidney disease/skin disorders[1][4][7], clinical application has been limited by poor solubility and low oral bioavailability. Various formulations including nanoparticles or salt forms have been developed to improve these properties[4]. As of now there are no approved pharmaceutical drugs containing mangiferin but it is used in dietary supplements such as Zynamite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mangiferin.